Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

Clinical trial NCT03943537 · COMPLETED

Trial details

NCT number: NCT03943537
Sponsor: Mclean Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psychosis Schizophrenia Schizo Affective Disorder Bipolar I Disorder

Start date: 2019-10-01
Primary completion: 2024-02-23
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.